The nasal spray had to go through many rounds of clinical testing, with some shown to improve depression, while others showed no improvement over a placebo. In 2019, the FDA approved Spravato for ...

Tesla and SpaceX CEO Elon Musk clarified that he uses only "a small amount once every other week or something like that" ...

In terms of the newest collaboration, the health care professionals said they decided that having all the services under one ...

Hikma Pharmaceuticals PLC (Hikma, Group), the multinational generic pharmaceutical company, announces the approval of KLOXXADO ® (naloxone HCl) Nasal Spray 8 mg, by Health Canada for the treatment of ...

A nasal spray, referred to as nasal anti-CD3 ... “It goes beyond their discharge, with all the spectrum of PTSD, anxiety, depression, and cognitive decline.” Following successful trials ...

Hikma Pharmaceuticals (HKMPF) announces the approval of KLOXXADO Nasal Spray 8 mg, by Health Canada for the treatment of known or suspected ...

Cisatracurium besylate injection has a market value of approximately $14 million in the 12 months ending January 2025, per ...

The oxytocin system-which helps release breast milk and strengthens the bond between mother and baby-may be affected during breastfeeding in mothers experiencing postnatal depression, finds a ...

Nasal Spray 8 mg, by Health Canada for the treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression, for adult patients. KLOXXADO ...